The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Pascale Adam since 2017.
The trader's CIK number is 1613377.
At the time of the last reporting, Pascale Adam was the CFO of Hemispherx Biopharma Inc. (stock ticker symbol HEB).
Also see all insider trading activities at Hemispherx Biopharma Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | HEB | 32,259 | $10,000 | 0 | $0 | 0 | $0 |
| 2017 | HEB | 22,854 | $13,210 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-07-23 | HEB | Buy | 32,259 | .31 | 10,000 |
| 2017-05-02 | HEB | Buy | 15,873 | .63 | 9,999 |
| 2017-02-16 | HEB | Buy | 6,981 | .46 | 3,211 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pascale Adam (CFO of Hemispherx Biopharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.